Výsledky vyhledávání - "MESH : Antirheumatic Agents"

MTX optimization or adding bDMARD equally improve disease activity in rheumatoid arthritis: results from the prospective study STRATEGE

Autor: Elena Zinovieva, Hélène Herman-Demars, Christophe Hudry, René-Marc Flipo, Cécile Gaujoux-Viala

Publikováno v: Rheumatology (Oxford, England)
Rheumatology
Rheumatology, 2022, 61 (1), pp.270-280. ⟨10.1093/rheumatology/keab274⟩

Objectives The STRATEGE (Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis) study aimed to describe treatment strategies in current practice in RA biologic DMARD (bDMARD)-naïve patients with an inadequate response t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d151455fe2207590be08622d28d25b8f
https://doi.org/10.1093/rheumatology/keab274

Zobrazit plný text záznamu

Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study

Autor: Philippe Le Corvoisier, Muriel Paul, Laetitia Penso, Laura Pina Vegas, Pascal Claudepierre, Emilie Sbidian

Publikováno v: Rheumatology
Rheumatology, Oxford University Press (OUP), 2022, 61 (4), pp.1589-1599. ⟨10.1093/rheumatology/keab522⟩

Objective Several biological DMARDs (bDMARDs) have demonstrated anti-inflammatory effects in PsA. However, their comparative cardiovascular safety profiles remain unknown. We evaluated the risk of major adverse cardiovascular events (MACEs) in PsA pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4ebc3a790a04adda3089ecf6386d58d
https://hal.archives-ouvertes.fr/hal-03692265

Zobrazit plný text záznamu

Factors influencing the choice of biologic therapy following Rituximab in patients with rheumatoid arthritis: A retrospective study using propensity score

Autor: Gaelle Vial, Anne Tournadre, Adeline Ruyssen-Witrand, Bruno Pereira, Anaïs De Pouilly, Christophe Richez, Claire Daïen, Laetitia Scouppe, Pascale Vergne-Salle, Cédric Lukas

Publikováno v: Joint Bone Spine
Joint Bone Spine, Elsevier Masson, 2020, 87 (1), pp.43-48. ⟨10.1016/j.jbspin.2019.07.008⟩

Objectives To assess factors influencing the choice and effectiveness of biological disease-modifying antirheumatic drugs (DMARDs) following failure of rituximab (RTX) in rheumatoid arthritis (RA), taking patient profile into account. Methods In a re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d877bcec6925adfca69ba95d8c6f8e0
https://doi.org/10.1016/j.jbspin.2019.07.008

Zobrazit plný text záznamu

Impact of disease activity and treatments on ovarian reserve in patients with rheumatoid arthritis in the ESPOIR cohort

Autor: Jacques Morel, Charlotte Oris, Anne Sophie Gremeau, Bruno Pereira, Martin Soubrier, Philippe Gaudin, Arnaud Constantin, Florence Brugnon, Lydie Dejou-Bouillet, Camille Valdeyron, Bernard Combe, Jean Luc Pouly, Vincent Sapin

Publikováno v: Rheumatology
Rheumatology, Oxford University Press (OUP), 2020, ⟨10.1093/rheumatology/keaa535⟩
Rheumatology, 2020, ⟨10.1093/rheumatology/keaa535⟩
Rheumatology, 2021, 60 (4), pp.1863-1870. ⟨10.1093/rheumatology/keaa535⟩

Objectives Patients with RA have a higher prevalence of infertility than the general population. This study sought to examine the impact of RA disease activity and treatments on ovarian reserve measured by serum anti-Müllerian hormone (AMH) levels i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0448aa9d6c60b12d938b59b3cc5354f6
https://hal.archives-ouvertes.fr/hal-03040700/document

Zobrazit plný text záznamu

Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study

Autor: Alain Saraux, Bernard Combe, Francis Fagnani, Gabrielle Cukierman, Isabelle Bru, Jean-Michel Joubert, Jan-Christof Schuller, Jacques Massol, Rene-Marc Flipo

Publikováno v: Clinical and experimental rheumatology
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2021, 39 (4), pp.781-789

International audience; Objectives: To describe the long-term effectiveness and safety of certolizumab pegol in patients with moderate-to-severe rheumatoid arthritis (RA) in a real-world setting in France.Methods: ECLAIR was a 3-year longitudinal, pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f43619c59d8b8175ba814c2a7fc280
https://hal.umontpellier.fr/hal-03340763

Zobrazit plný text záznamu

Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis

Autor: Fogel, Olivier, Bugge Tinggaard, Andreas, Fagny, Maud, Sigrist, Nelly, Roche, Elodie, Leclere, Laurence, Deleuze, Jean-François, Batteux, Frederic, Dougados, Maxime, Miceli-Richard, Corinne, Tost, Jörg

Publikováno v: Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-14 (2019)
Fogel, O, Bugge Tinggaard, A, Fagny, M, Sigrist, N, Roche, E, Leclere, L, Deleuze, J F, Batteux, F, Dougados, M, Miceli-Richard, C & Tost, J 2019, ' Deregulation of microRNA expression in monocytes and CD4 + T lymphocytes from patients with axial spondyloarthritis ', Arthritis Research and Therapy, vol. 21, no. 1, 51 . https://doi.org/10.1186/s13075-019-1829-7
Arthritis Research & Therapy
Arthritis Research & Therapy, 2019, 21 (1), pp.1-14. ⟨10.1186/s13075-019-1829-7⟩

BACKGROUND: MicroRNAs (MiRs) play an important role in the pathogenesis of chronic inflammatory diseases. This study is the first to investigate miR expression profiles in purified CD4+ T lymphocytes and CD14+ monocytes from patients with axial spond

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::01ef52145922e8a7a7ed78dcfaf772cc
http://link.springer.com/article/10.1186/s13075-019-1829-7

Zobrazit plný text záznamu

Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry

Autor: Lukas, Cédric, Redondin, Manon, Pane, Isabelle, Soubrier, Martin, Houvenagel, Eric, Sibilia, Jean, Combe, Bernard, Morel, Jacques

Publikováno v: Clinical and experimental rheumatology
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2021, 39 (3), pp.501-507

International audience; Objectives: Rheumatoid arthritis (RA) is responsible for excess mortality mainly due to cardiovascular disease. Studies have found elevated cholesterol levels in RA patients who received tocilizumab (TCZ). We studied the occur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::857bff0ef84b47025a4f445a607b3458
https://hal.umontpellier.fr/hal-03340700

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání